Research and Funding

Funding Opportunities

Nanoscience and Nanotechnology in Biology and Medicine (R21)

Funding Number: PA-11-149
Funding Type: PA
Release Date: March 14, 2011
Expiration Date: May 8, 2014
Web Site:
This initiative, issued by the National Institutes of Health, encourages applications from institutions/organizations that apply nanoscience and nanotechnology approaches to address problems in biology and medicine. The purpose of this FOA is to provide support for cutting-edge nanoscience and nanotechnology research that can lead to biomedical breakthroughs and new investigations into the diagnosis, treatment and management of an array of diseases and traumatic injuries. Nanoscience and nanotechnology have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes and systems based on the advancement of our understanding of biology at the nanoscale. Therefore, this FOA will also support research projects that develop new or improved nanotechnology and nanoscience-based tools, methods, concepts, and devices that lead to a better understanding of basic biology in addition to conducting translational biomedical studies. Because this FOA utilizes the R21 grant mechanisms, applications that focus on novel or exploratory approaches that are risky but have potentially a high impact are encouraged as well as proposed discovery research that may lead to new areas of biomedical investigations.